BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Milind R, Attwood SE. Natural history of Barrett's esophagus. World J Gastroenterol 2012; 18(27): 3483-3491 [PMID: 22826612 DOI: 10.3748/wjg.v18.i27.3483] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Al-Zahrani MS, Alhassani AA, Zawawi KH. Clinical manifestations of gastrointestinal diseases in the oral cavity. Saudi Dent J 2021;33:835-41. [PMID: 34938023 DOI: 10.1016/j.sdentj.2021.09.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
2 Maitra I, Morais CL, Lima KM, Ashton KM, Bury D, Date RS, Martin FL. Discrimination of oesophageal transformation stages to adenocarcinoma in human tissue samples using Raman microspectroscopy. Vibrational Spectroscopy 2020;111:103141. [DOI: 10.1016/j.vibspec.2020.103141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Maitra I, Morais CLM, Lima KMG, Ashton KM, Date RS, Martin FL. Raman spectral discrimination in human liquid biopsies of oesophageal transformation to adenocarcinoma. J Biophotonics 2020;13:e201960132. [PMID: 31794123 DOI: 10.1002/jbio.201960132] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
4 Maitra I, Morais CLM, Lima KMG, Ashton KM, Date RS, Martin FL. Attenuated total reflection Fourier-transform infrared spectral discrimination in human bodily fluids of oesophageal transformation to adenocarcinoma. Analyst 2019;144:7447-56. [DOI: 10.1039/c9an01749f] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
5 Lewis JT. Reflux Esophagitis and Barrett Esophagus. Surgical Pathology of Non-neoplastic Gastrointestinal Diseases 2019. [DOI: 10.1007/978-3-030-15573-5_3] [Reference Citation Analysis]
6 Dimou FM, Gonzalez C, Velanovich V. Utility of Endoscopy in the Diagnosis of Hiatus Hernia and Correlation with GERD. Hiatal Hernia Surgery 2018. [DOI: 10.1007/978-3-319-64003-7_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Amadi C, Gatenby P. Barrett’s oesophagus: Current controversies. World J Gastroenterol 2017; 23(28): 5051-5067 [PMID: 28811703 DOI: 10.3748/wjg.v23.i28.5051] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
8 Johnson DA, Katz PO, Armstrong D, Cohen H, Delaney BC, Howden CW, Katelaris P, Tutuian RI, Castell DO. The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus. Drugs 2017;77:547-61. [PMID: 28233274 DOI: 10.1007/s40265-017-0712-6] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 7.7] [Reference Citation Analysis]
9 Riddiough GE, Hornby ST, Asadi K, Aly A. Gastric adenocarinoma of the upper oesophagus: A literature review and case report. Int J Surg Case Rep. 2017;30:205-214. [PMID: 28086198 DOI: 10.1016/j.ijscr.2016.11.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
10 Babic Z, Bogdanovic Z, Dorosulic Z, Petrovic Z, Kujundzic M, Banic M, Marusic M, Heinzl R, Bilić B, Andabak M. One year treatment of Barrett s oesophagus with proton pump inhibitors (a multi-center study). Acta Clinica Belgica 2015;70:408-13. [DOI: 10.1179/2295333715y.0000000050] [Reference Citation Analysis]
11 Oguma J, Ozawa S, Kazuno A, Nitta M, Ninomiya Y, Tomita S. Two-year follow-up period showing the natural history of a superficial esophageal adenocarcinoma arising in a long segment of Barrett's esophagus. Clin J Gastroenterol 2016;9:289-92. [PMID: 27590624 DOI: 10.1007/s12328-016-0681-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Hu Y, Puri V, Shami VM, Stukenborg GJ, Kozower BD. Comparative Effectiveness of Esophagectomy Versus Endoscopic Treatment for Esophageal High-grade Dysplasia. Ann Surg. 2016;263:719-726. [PMID: 26672723 DOI: 10.1097/sla.0000000000001387] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
13 Whitson MJ, Falk GW. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus. Gastroenterol Clin North Am 2015;44:299-315. [PMID: 26021196 DOI: 10.1016/j.gtc.2015.02.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
14 Attwood S. New Barrett's guidelines: an opportunity to improve patient experience and save resources. Frontline Gastroenterol 2015;6:4-5. [PMID: 28840918 DOI: 10.1136/flgastro-2014-100486] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 McDonald SA, Lavery D, Wright NA, Jansen M. Barrett oesophagus: lessons on its origins from the lesion itself. Nat Rev Gastroenterol Hepatol 2015;12:50-60. [PMID: 25365976 DOI: 10.1038/nrgastro.2014.181] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 7.6] [Reference Citation Analysis]
16 Connor MJ, Springford LR, Kapetanakis VV, Giuliani S. Esophageal atresia and transitional care--step 1: a systematic review and meta-analysis of the literature to define the prevalence of chronic long-term problems. Am J Surg. 2015;209:747-759. [PMID: 25605033 DOI: 10.1016/j.amjsurg.2014.09.019] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 5.2] [Reference Citation Analysis]
17 Han YM, Park JM, Lee HJ, Kim EH, Hahm KB. Short-term Intervention to Revert Premalignant Lesions as Strategy to Prevent Gastrointestinal Cancers. J Cancer Prev 2013;18:289-97. [PMID: 25337558 DOI: 10.15430/jcp.2013.18.4.289] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
18 Morrow E, Bushyhead D, Wassenaar E, Hinojosa M, Loviscek M, Pellegrini C, Oelschlager B. The impact of laparoscopic anti-reflux surgery in patients with Barrett’s esophagus. Surg Endosc. 2014;28:3279-3284. [PMID: 24935200 DOI: 10.1007/s00464-014-3601-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
19 Fujita M, Nakamura Y, Kasashima S, Furukawa M, Misaka R, Nagahara H. Risk factors associated with Barrett’s epithelial dysplasia. World J Gastroenterol 2014; 20(15): 4353-4361 [PMID: 24764673 DOI: 10.3748/wjg.v20.i15.4353] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
20 Morrow EH, Oelschlager BK. Surgery for Barrett’s Esophagus: From Metaplasia to Cancer. Surgical Management of Benign Esophageal Disorders 2014. [DOI: 10.1007/978-1-4471-5484-6_16] [Reference Citation Analysis]
21 Langevin SM, Michaud DS, Marsit CJ, Nelson HH, Birnbaum AE, Eliot M, Christensen BC, McClean MD, Kelsey KT. Gastric reflux is an independent risk factor for laryngopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2013;22:1061-1068. [PMID: 23703970 DOI: 10.1158/1055-9965.epi-13-0183] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 5.4] [Reference Citation Analysis]
22 Jo HJ, Lee HS, Kim N, Nam RH, Chang H, Kim MS, Kim SE, Oh JC, Lee DH, Jung HC. Predictable Marker for Regression of Barrett's Esophagus by Proton Pump Inhibitor Treatment in Korea. J Neurogastroenterol Motil 2013;19:210-8. [PMID: 23667752 DOI: 10.5056/jnm.2013.19.2.210] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]